These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 9463180)

  • 61. Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome.
    Toscani M; Migliavacca R; Sisson de Castro JA; Spritzer PM
    Metabolism; 2007 Jul; 56(7):992-7. PubMed ID: 17570263
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Treatment of hyperandrogenic manifestations in polycystic ovary syndrome].
    Bednarek-Tupikowska G; Milewicz A; Bohdanowicz-Pawlak A; Bidzińska B; Szymczak J
    Pol Tyg Lek; 1993 Jul 5-12; 48(27-28):620-3. PubMed ID: 8090657
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Long-term efficacy and tolerability of flutamide combined with oral contraception in moderate to severe hirsutism: a 12-month, double-blind, parallel clinical trial.
    Calaf J; López E; Millet A; Alcañiz J; Fortuny A; Vidal O; Callejo J; Escobar-Jiménez F; Torres E; Espinós JJ;
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3446-52. PubMed ID: 17566093
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Update on idiopathic hirsutism: diagnosis and treatment.
    Erem C
    Acta Clin Belg; 2013; 68(4):268-74. PubMed ID: 24455796
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prevalence of polycystic ovary syndrome in women seeking treatment from community electrologists. Alabama Professional Electrology Association Study Group.
    Farah L; Lazenby AJ; Boots LR; Azziz R
    J Reprod Med; 1999 Oct; 44(10):870-4. PubMed ID: 10554748
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Androgens in women: Hormone-modulating therapies for skin disease.
    Azarchi S; Bienenfeld A; Lo Sicco K; Marchbein S; Shapiro J; Nagler AR
    J Am Acad Dermatol; 2019 Jun; 80(6):1509-1521. PubMed ID: 30312645
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment of hirsutism in women with flutamide.
    Marcondes JA; Minnani SL; Luthold WW; Wajchenberg BL; Samojlik E; Kirschner MA
    Fertil Steril; 1992 Mar; 57(3):543-7. PubMed ID: 1531466
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hirsutism in Women.
    Matheson E; Bain J
    Am Fam Physician; 2019 Aug; 100(3):168-175. PubMed ID: 31361105
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The use of antiandrogen flutamide in the treatment of hirsutism.
    Cesur V; Kamel N; Uysal AR; Erdoğan G; Başkal N
    Endocr J; 1994 Oct; 41(5):573-7. PubMed ID: 7889119
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cost-effective therapy in patients with idiopathic hirsutism.
    Lumachi F; Zulian E; Scaroni C
    Expert Rev Pharmacoecon Outcomes Res; 2004 Jun; 4(3):297-306. PubMed ID: 19807312
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hirsutism in women.
    Bode D; Seehusen DA; Baird D
    Am Fam Physician; 2012 Feb; 85(4):373-80. PubMed ID: 22335316
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Very low dose of flutamide in the treatment of hyperandrogenism.
    Fulghesu AM; Melis F; Murru G; Canu E; Melis GB
    Gynecol Endocrinol; 2018 May; 34(5):394-398. PubMed ID: 29108453
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antiandrogen drugs lower serum prostate-specific antigen (PSA) levels in hirsute subjects: evidence that serum PSA is a marker of androgen action in women.
    Negri C; Tosi F; Dorizzi R; Fortunato A; Spiazzi GG; Muggeo M; Castello R; Moghetti P
    J Clin Endocrinol Metab; 2000 Jan; 85(1):81-4. PubMed ID: 10634368
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of flutamide and cyproterone acetate in the treatment of hirsutism: a randomized controlled trial.
    Grigoriou O; Papadias C; Konidaris S; Antoniou G; Karakitsos P; Giannikos L
    Gynecol Endocrinol; 1996 Apr; 10(2):119-23. PubMed ID: 8701785
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The efficacy of 250 mg/day flutamide in the treatment of patients with hirsutism.
    Müderris II; Bayram F; Sahin Y; Keleştimur F; Tutuş A; Ayata D
    Fertil Steril; 1996 Aug; 66(2):220-2. PubMed ID: 8690105
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Management of hirsutism.
    Falsetti L; Gambera A; Platto C; Legrenzi L
    Am J Clin Dermatol; 2000; 1(2):89-99. PubMed ID: 11702316
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The risk of hepatotoxicity during long-term and low-dose flutamide treatment in hirsutism.
    Dikensoy E; Balat O; Pence S; Akcali C; Cicek H
    Arch Gynecol Obstet; 2009 Mar; 279(3):321-7. PubMed ID: 18607612
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical practice. Hirsutism.
    Rosenfield RL
    N Engl J Med; 2005 Dec; 353(24):2578-88. PubMed ID: 16354894
    [No Abstract]   [Full Text] [Related]  

  • 79. Low-dose flutamide (125 mg/day) as maintenance therapy in the treatment of hirsutism.
    Venturoli S; Paradisi R; Bagnoli A; Colombo FM; Ravaioli B; Vianello F; Mancini F; Gualerzi B; Porcu E; Seracchioli R
    Horm Res; 2001; 56(1-2):25-31. PubMed ID: 11815724
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Management of hirsutism.
    Alsantali A; Shapiro J
    Skin Therapy Lett; 2009 Sep; 14(7):1-3. PubMed ID: 20039595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.